Tandem Diabetes Care TNDM
NASDAQ TNDM
$16.50 +0.19 (+1.16%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tandem Diabetes Care (TNDM) Equity Income (2024 - 2026)

Updated

Tandem Diabetes Care (TNDM) recorded Equity Income of -$5.64 million in Q2 2026, compared with -$3.4 million a year earlier.

Analysis

Tandem Diabetes Care (TNDM) Equity Income (2024 - 2026) Analysis & Trends

On a TTM basis, Tandem Diabetes Care's Equity Income came in at -$16.82 million as of Jun 30, 2026; for FY2025, it was -$14.2 million.

  • Across earlier years, Equity Income came in at -$2.1 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$3.9 million (Q1 2026), -$4.56 million (Q4 2025) and -$2.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -15.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Tandem Diabetes Care 1.13 Bn -503.83 Mn 144.78 Mn -5.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.64 Mn
Mar 31, 2026 -3.90 Mn
Dec 31, 2025 -4.56 Mn
Sep 30, 2025 -2.72 Mn
Jun 30, 2025 -3.40 Mn
Mar 31, 2025 -3.54 Mn
Dec 31, 2024 -2.10 Mn
API Access

Tandem Diabetes Care Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=TNDM&period=max&api_key=YOUR_API_KEY